Gilmore O'Neill - Jun 21, 2024 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
Director
Signature
/s/ Alexander Nguyen, Attorney-in-Fact for Gilmore Neil O'Neill
Stock symbol
UBX
Transactions as of
Jun 21, 2024
Transactions value $
$0
Form type
4
Date filed
6/21/2024, 04:30 PM
Previous filing
Jun 6, 2024
Next filing
Sep 6, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UBX Stock Option (Right to Buy) Award $0 +10K $0.00 10K Jun 21, 2024 Common Stock 10K $1.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 21, 2024 or (ii) the date of the 2025 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date.